Page last updated: 2024-08-24

simendan and Hypertrophy, Right Ventricular

simendan has been researched along with Hypertrophy, Right Ventricular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, A; Andersen, S; Hillgaard, TK; Nielsen, JM; Nielsen-Kudsk, JE; Ringgaard, S; Vildbrad, MD	1

Other Studies

1 other study(ies) available for simendan and Hypertrophy, Right Ventricular

Article	Year
Levosimendan Prevents Pressure-Overload-induced Right Ventricular Failure. Journal of cardiovascular pharmacology, 2016, Volume: 67, Issue:4 Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Heart Failure; Hydrazones; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging; Male; Myocardial Contraction; Pyridazines; Rats; Rats, Wistar; Simendan; Ventricular Dysfunction, Right; Ventricular Function, Right	2016

Article

Year

Levosimendan Prevents Pressure-Overload-induced Right Ventricular Failure.

Journal of cardiovascular pharmacology, 2016, Volume: 67, Issue:4

Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Heart Failure; Hydrazones; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging; Male; Myocardial Contraction; Pyridazines; Rats; Rats, Wistar; Simendan; Ventricular Dysfunction, Right; Ventricular Function, Right

2016